Borrelia-WB-IgM

Serum

Reference range:

Understanding the Borrelia WB IgM Biomarker and Its Role in Lyme Disease Diagnosis

The Borrelia Western Blot (WB) IgM test is a significant tool in the diagnosis of Lyme disease, an infection caused by the Borrelia burgdorferi bacteria, transmitted primarily through tick bites. The IgM test specifically detects early immune responses to the bacteria and is a valuable marker during the initial weeks following exposure. The presence of IgM antibodies, which are the first line of defense, provides insight into whether an infection is recent, as IgM antibodies typically appear within one to two weeks of exposure and may decline after a few months. Given that Lyme disease can present with a range of symptoms that mimic other illnesses, accurately interpreting IgM and other biomarkers is essential for both timely treatment and effective management of the disease.

What is Borrelia WB IgM?

IgM (Immunoglobulin M) is one of the earliest antibodies produced by the immune system when it encounters a foreign pathogen like Borrelia burgdorferi. In Lyme disease, IgM antibodies specifically target unique proteins on the Borrelia bacteria’s cell surface. The Western Blot test is a method that separates these proteins by their size, allowing for the identification of specific antibodies that bind to Borrelia proteins, thus helping to confirm infection. For Borrelia WB IgM, a positive result requires reactivity against at least two out of three specific protein bands: 24 kDa (OspC), 39 kDa (BmpA), and 41 kDa (flagellin). If these bands are present, it generally suggests a recent infection with Borrelia, as the IgM response occurs early and may subside as the infection progresses.

Importance of IgM in the Early Stages of Lyme Disease

The IgM test is especially significant within the first 4-6 weeks of infection, as the immune system initially mounts an IgM response before producing IgG antibodies, which provide longer-lasting immunity. A positive IgM result alongside Lyme-specific symptoms (such as fever, fatigue, joint pain, and in some cases, the characteristic bullseye rash) supports a diagnosis of early Lyme disease and indicates that the infection is likely recent. Prompt diagnosis based on IgM positivity can be crucial, as early treatment with antibiotics can prevent the progression of Lyme disease to more advanced, chronic stages.

It is important to note that IgM antibodies may also remain detectable for a period after infection, even as symptoms subside or resolve, sometimes resulting in lingering IgM reactivity for months. Therefore, a positive IgM test alone does not always indicate an active infection; it must be interpreted within the clinical context, especially if symptoms have resolved or if the patient has been treated previously.

The Relationship Between IgM, P100, and IgG in Lyme Disease

In the broader context of Lyme disease diagnostics, the IgM biomarker often works alongside other markers such as P100 and IgG to create a more comprehensive picture of the infection status. While IgM is associated with the early response, IgG represents a more established immune response that appears later and provides a longer-term indication of exposure. IgG antibodies often develop after 4-6 weeks of infection and can remain detectable for years, even after the infection has resolved. In the Western Blot IgG test, a positive result requires reactivity to at least 5 out of 10 specified bands, reflecting a more mature immune response.

The P100 biomarker, in particular, has a unique role in this diagnostic landscape. P100 is a protein antigen that appears mainly in later stages of the infection or in cases where the immune system has been engaged for an extended period. It is often more relevant in chronic or late-stage Lyme disease, where a patient’s immune system continues to show signs of response to Borrelia antigens long after initial exposure. A positive P100 may indicate that a patient had a prolonged or persistent infection, especially if combined with positive IgG markers.

However, P100 does not typically appear in the early stages of infection and is not included in the standard criteria for diagnosing acute Lyme disease. Thus, in an initial diagnostic panel, IgM and IgG are the primary markers used to identify early and progressing infections. If IgM is positive and P100 is negative, it may suggest a recent infection that has not yet stimulated an immune response to proteins like P100, which emerge later. Conversely, if both IgG and P100 are positive but IgM is negative, it could indicate a past or chronic infection rather than an active, acute infection.

Clinical Interpretation of Borrelia WB IgM in Relation to Other Markers

Interpreting Borrelia WB IgM in conjunction with IgG and P100 can be challenging, as the immune response to Borrelia burgdorferi is known to vary between individuals. Additionally, Lyme disease’s unique ability to evade immune detection can result in fluctuating antibody levels over time, complicating interpretation. Therefore, the timing of symptom onset, recent tick exposure, and progression of symptoms are key factors in determining the diagnostic significance of each marker.

In cases where only IgM is positive, but IgG and P100 are negative, the finding suggests a potential early infection that warrants further clinical follow-up and possibly retesting after a few weeks. If symptoms persist or worsen, IgG and P100 may eventually become positive, reflecting a transition to a later stage of immune response.

When IgG is positive and IgM is negative, it generally indicates an older infection or residual antibodies from a past exposure that the immune system has recognized and responded to over time. If both IgG and P100 are positive, it could suggest that the infection has been present for a longer period or that the body is still actively producing antibodies in response to persistent symptoms. A positive P100 in this case is often associated with a chronic immune response, while a negative IgM suggests that the infection is not in its earliest phase.

Limitations and Challenges of IgM Testing

Despite its utility, the Borrelia WB IgM test has limitations. False positives can occur, especially in individuals with autoimmune diseases or those who have experienced other infections that elicit similar antibody responses. Moreover, some patients may test positive for IgM without developing a full-blown Lyme infection or may have a transient IgM response that doesn’t progress to IgG positivity. Consequently, the CDC recommends caution in interpreting IgM results after the first month of symptoms, as lingering IgM without IgG or P100 reactivity might not indicate active infection.

Additionally, some patients with Lyme disease may not produce detectable IgM antibodies at all, particularly if they have a weakened immune response or if testing occurs too late in the infection cycle. Therefore, negative IgM results do not conclusively rule out Lyme disease, particularly in patients with symptoms consistent with the infection. In these cases, clinicians may consider retesting after a few weeks, or using additional testing methods, such as PCR, which detects Borrelia DNA rather than relying solely on antibody responses.

Conclusion

The Borrelia WB IgM biomarker plays a crucial role in identifying early Lyme disease, signaling the body’s initial immune response to Borrelia burgdorferi. When used in combination with IgG and P100, IgM provides valuable insights into the timing and progression of the infection. While IgM is most relevant in the early phase, IgG and P100 are associated with a later or chronic immune response. A comprehensive assessment of all three markers, along with clinical context, allows for a more nuanced understanding of a patient’s Lyme disease status. This approach helps guide treatment decisions and ensures that both recent and past infections are accurately evaluated, enabling timely intervention and improving patient outcomes.

Frequently asked questions

Healthmatters is a highly-personalized health dashboard.

Instead of searching for your lab results in different places or tracking them down from different providers, Healthmatters houses, organizes, and interprets them all in one central location.

With a Healthmatters account, you can dive into the details of each biomarker and gain insights into the meaning behind your medical test data, anytime, anywhere.

For our professional users, Healthmatters provides intuitive tools that not only streamline analysis but also save valuable time when delving into your client's lab report history.

Healthmatters.io personal account provides in-depth research on 4000+ biomarkers, including information and suggestions for test panels such as, but not limited to:

  • The GI Effects® Comprehensive Stool Profile,
  • GI-MAP,
  • The NutrEval FMV®,
  • The ION Profile,
  • Amino Acids Profile,
  • Dried Urine Test for Comprehensive Hormones (DUTCH),
  • Organic Acids Test,
  • Organix Comprehensive Profile,
  • Toxic Metals,
  • Complete Blood Count (CBC),
  • Metabolic panel,
  • Thyroid panel,
  • Lipid Panel,
  • Urinalysis,
  • And many, many more.

You can combine all test reports inside your Healthmatters account and keep them in one place. It gives you an excellent overview of all your health data. Once you retest, you can add new results and compare them.

If you are still determining whether Healthmatters support your lab results, the rule is that if you can test it, you can upload it to Healthmatters.

While we work with many popular labs, we welcome reports from lots of other places too.

It's as simple as this: if you can get a test done, you can upload it to Healthmatters and we can interpret results from any lab out there. If laboratories can analyze it, we can interpret it.

If you’re on the hunt for a specific biomarker, contact us and we'll add it to our database. Anything from blood, urine, saliva, or stool can be uploaded, understood, and tracked with your Healthmatters account.

There are two ways to add your test reports to your Healthmatters account. One option is to input the data using the data entry forms. The other method is to utilize our "Data entry service."

Our data entry forms offer an easy, fast, and free way for you to input the reports yourself. Self-entry allows you to add an unlimited number of reports at no cost. We make the self-entry process user-friendly, providing dozens of templates that pre-populate the most popular laboratory panels and offering instant feedback on entered values.

For those who prefer assistance, we offer a "Data entry service" to help you input your data. Simply attach an image or file of your lab test results, and a qualified team member from our data entry team will add the results for you.

We support various file types, including PDFs, JPGs, or Excel. This service is particularly useful if you have many reports to upload or if you're too busy to handle the data entry yourself.

Our special data entry service makes it easy to add your results to your private dashboard. Just attach an image or a file of your lab test results, and our skilled data entry team will do the work for you. It's all done by humans, ensuring that your data is entered accurately and with personal care for each client.

Depending on your account, the data entry service can be included for free or come at an additional cost of $15 per report.

For users on the Complete monthly plan, the first report is entered free of charge, and each additional report incurs a fee of $15.

Unlimited account holders enjoy the entry of ten reports without charge. Subsequent reports are subject to a $15 fee per report.

Additionally, users on the Complete plan can upgrade to a yearly subscription from the account settings. The annual subscription includes a data entry service for five reports.

The Unlimited plan is a one-time purchase for $250, and it covers your account for a lifetime with no additional payments.

For the Complete plan, the cost is $15 per month. You have the flexibility to cancel it anytime through your account settings, ensuring no further payments. To avoid charges, remember to cancel at least a day before the renewal date. Once canceled, the subscription remains active until the end of the current billing cycle.

Additionally, you can upgrade to the yearly Advanced plan from within your account. The annual cost is $79, and it comes with a data entry service for five reports.

You can always upgrade to a lifetime version with a prorated price from a monthly or yearly subscription.

Simply log in and navigate to your account settings to cancel your subscription. Scroll down to locate the 'Cancel' button at the bottom of the page. Ensure you cancel at least one day before the renewal date to prevent any charges. Once cancellation is requested, the subscription remains active until the conclusion of the current billing cycle.

Our goal has been to make your Healthmatters account as intuitive as possible.

We’ve crafted multiple ways for you to navigate your data, whether you're glancing at a single report or delving into your historical test reports.

1. Graph View:

Dive into a visual journey with our biomarker graphs, showcasing over 40 data points. Combining years of results unveils trends, empowering you to make informed decisions. Our visualization tools make it a breeze to compare and understand changes over time, even if your results are from different labs. A search function and filters simplify the exploration of extensive data, allowing you to focus on what needs attention.

2. All Tests View

Explore neatly organized reports on a timeline, highlighting crucial details like dates, critical results, and lab/panel names. Each report opens up to reveal in-depth descriptions and additional recommendations for each biomarker. The history of previous results is just a click away, and you can download a comprehensive report for deeper insights. Color-coded and user-friendly, it's designed for easy reading, understanding, and navigation.

3. Table View:

For a holistic view of all biomarkers side by side, our table view is your go-to. Results are neatly displayed in a categorized and dated table, ideal for those with an extensive test history. Utilize sorting, filters, and color-coding to enhance your analysis and gain extra insights.

Yes, you can download information from your account. We can compile your labs into a CSV file. To download all your labs, you can go to Account Settings, and at the bottom of the page, you will find a link to download your information.

Yes, you can print your report. To do so, navigate to "All tests" and open the report you wish to print. You'll find a print button in the right corner of the report. Click on it, and your browser's print window will open. If you prefer to print in a bigger typeface, adjust the scale using the print window settings.

Yes, you can! We highly recommend activating Two-Factor Authentication (2FA) for your account. To do so, please navigate to the "Profile and Security" section of your account, where you will find instructions for activating 2FA.

Yes, you can. When entering values for the biomarker, you will see an "Edit Range" button. Click this button, and you'll have the option to enter a custom range.

A personal account is all about keeping your own lab test results in check. It's just for you and your personal use.

The professional account is designed for health professionals who wish to track and organize their clients' laboratory results.

Use promo code to save 10% off any plan.


We implement proven measures to keep your data safe.

At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.